Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.81

Bid

3.81

Ask

3.90

Volume

26,624

3.62 Day's Range 4.16

0.3691 52 Week Range 7.341

Market Cap

3.041M

Previous Close

3.89

Open

4.12

Last Trade

3.9

Last Trade Time

Financial Volume

$ 103,399

VWAP

3.8837

Average Volume (3m)

93,020

Shares Outstanding

798,176

Dividend Yield

PE Ratio

-0.20

Earnings Per Share (EPS)

-18.64

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $3.89. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.3691 to $ 7.341.

Alzamend Neuro currently has 798,176 shares outstanding. The market capitalization of Alzamend Neuro is $3.10 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.20.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.14	-3.54430379747	3.95	4.24	3.27	25070	3.79130523	CS
4	3.419	874.42455243	0.391	4.42	0.3707	62812	1.07704225	CS
12	3.075	418.367346939	0.735	4.42	0.3691	93020	0.6584656	CS
26	2.88	309.677419355	0.93	4.42	0.3691	71507	0.79144766	CS
52	-2.94	-43.5555555556	6.75	7.341	0.3691	131804	2.31354454	CS
156	-75.39	-95.1893939394	79.2	101.1	0.3691	1050794	33.55838306	CS
260	-431.19	-99.124137931	435	503.25	0.3691	1129935	41.73590689	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M